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Cardiac computed tomography: indications, applications,
limitations, and training requirements: report of a writing group
deployed by the working group nuclear cardiology and cardiac
CT of the european society of cardiology and the european
council of nuclear cardiology
Abstract
As a consequence of improved technology, there is growing clinical interest in the use of multi-detector
row computed tomography (MDCT) for non-invasive coronary angiography. Indeed, the accuracy of
MDCT to detect or exclude coronary artery stenoses has been high in many published studies. This
report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT (WG 5)
of the European Society of Cardiology and the European Council of Nuclear Cardiology summarizes the
present state of cardiac CT technology, as well as the currently available data concerning its accuracy
and applicability in certain clinical situations. Besides coronary CT angiography, the use of CT for the
assessment of cardiac morphology and function, evaluation of perfusion and viability, and analysis of
heart valves is discussed. In addition, recommendations for clinical applications of cardiac CT imaging
are given and limitations of the technique are described.
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As a consequence of improved technology, cardiac imaging by multi-detector computed 
tomography (MDCT) has become increasingly stable. There is growing clinical interest 
in the use of MDCT imaging, especially for, but not limited to, coronary CT angiography. 
Indeed, the accuracy of CT to detect coronary artery stenoses has been high in many 
published studies, but detailed knowledge of the potential and limitations of CT imaging 
is necessary to make clinically beneficial use of CT while avoiding its use in situation 
where CT imaging is unlikely to contribute to patient management.  
This report of a Study Group deployed by the Working Group Nuclear Cardiology and 
Cardiac CT (WG 5) of the European Society of Cardiology and  the European Council of 
Nuclear Cardiology summarizes the present state of cardiac CT technology, as well as 
the currently available data concerning its accuracy and applicability in certain clinical 
situations. Besides coronary CT angiography, the use of CT for risk stratification, 
imaging of cardiac morphology and function, analysis of cardiac valves, and 
assessment of perfusion and viability are considered. Recommendations for clinical 
applications of cardiac CT imaging are given and limitations of the technique are 
described.  
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1. Introduction  
The introduction of multi-detector row computed tomography (MDCT) in 1999 led to a 
significant improvement in the temporal and spatial resolution of CT, which permitted 
substantial expansion of potential indications for CT imaging. Small and rapidly moving 
anatomic structures could be visualized with good image quality, and early experience 
with the initial 4-slice scanners demonstrated the potential of MDCT to visualize the 
heart and even the coronary arteries.  
The possibility to perform cardiac and coronary imaging was a major driving force 
behind an ongoing, rapid evolution of scanner technology, accompanied by 
improvements of software and post-processing tools. The most recent generations of 
MDCT with the ability to acquire 64 or more slices simultaneously allow relatively robust 
morphologic and functional imaging of the heart. While initially, clinical applications were 
restricted to the detection of coronary calcium, visualization of the coronary artery lumen 
(non-invasive coronary angiography) has now become the major focus of cardiac 
MDCT. In addition, the assessment of non-stenotic coronary atherosclerotic plaques, of 
coronary stents or bypass grafts has become possible in selected situations, as well as 
the evaluation of left and right ventricular function, some aspects of valvular function, 
coronary and pulmonary veins, and general morphology of the heart and great vessels.  
The present manuscript summarizes the current status of technology and clinical 
applications of cardiac computed tomography, with a special emphasis on coronary CT 
angiography. 
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2. Technical Background and Data Acquisition 
The introduction of MDCT has provided the technical requirements to perform cardiac 
imaging with CT. Multiple detector rows permit high-resolution imaging with a short 
overall data acquisition time, and the increased gantry rotation speed, together with 
dedicated ECG-gated image reconstruction algorithms, provide for high temporal 
resolution and the ability to obtain phase-correlated image data sets. 4-slice MDCT, 
introduced around the year 2000 1-3, provided the first evidence that mechanical CT 
scanning of the heart and coronary arteries is feasible, but was burdened with a high 
rate of unevaluable studies, mostly due to insufficient temporal resolution. Currently, 64-
slice CT is considered state-of-the-art for cardiac CT imaging.  
While “sequential” imaging (so-called “step-and-shoot” mode) is used in some 
instances, cardiac CT is usually based on continuous spiral scanning of the heart with a 
very low pitch (table feed/gantry rotation) in order to achieve oversampling of  
information across different phases of the cardiac cycle and in some cases even across 
several consecutive cardiac cycles. Simultaneous recording of the patient’s 
electrocardiogram (ECG) allows retrospective reconstruction of images at any desired 
phase of the cardiac cycle, which in turn provides for identification of the time instant in 
which the cardiac structures show the least residual motion. In addition, the ability to 
reconstruct data sets at multiple time instants during the cardiac cycle allows for 
“dynamic” imaging and analysis of function.  
Coronary artery visualization requires the acquisition of CT data with the highest 
temporal and spatial resolution. With current 64-slice CT systems, data acquisition is 
performed within a single breath-hold of about 6-12 seconds. Synchronization of data 
acquisition and contrast enhancement can be achieved by calculating the veno-arterial 
transit time using a small bolus of contrast agent and retrospective analysis of the 
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enhancement pattern over time (so-called “test bolus” technique), or by real-time 
monitoring of the arrival of the bolus, for example in the ascending aorta (so-called 
“bolus tracking” technique). Typically, the amount of contrast material required for 
coronary CT angiography is about 60-100ml depending on scanner type, patient size, 
heart rate and body mass index. Contrast agent should be of high iodine concentration. 
Usually, the flow rate is 5 ml/s, but especially in obese patients, increasing the flow rate 
may be advantageous.  
After acquisition of the raw data, retrospectively ECG-gated image data sets are 
generated. These data sets consist usually of 200 to 300 thin (0.5 to 0.75 mm) and 
overlapping slices in transaxial orientation. Especially for coronary artery imaging, it is 
important to carefully identify the time instant in the cardiac cycle which shows least 
cardiac motion. For lower heart rates, the best time instant is usually in mid- to end-
diastole phase while for higher heart rates, reconstruction in end-systole may yield 
superior results 4-6. The patient’s average heart rate and heart rate variability have been 
shown to substantially influence image quality. As the most important predictor for 
diagnostic image quality, a low (<60bpm) and regular heart rate (HR <±2bpm) has 
been identified 7-11. For this reason, beta blockers are frequently administered prior to 
the CT scan in order to lower heart rate and to obtain robust image quality 12. 
Nitroglycerine should routinely be administered sublingually to achieve vasodilatation 
with optimal opacification and visualization of the coronary arteries 13. 
 
Radiation Exposure  The effective radiation dose of a contrast-enhanced cardiac 
CT scan is approximately 5-20 mSv 14-28. Numerous factors influence radiation dose. 
Reductions in radiation dose can be achieved by obvious and straightforward 
measures, such as keeping the length of the scan volume as short and tube current as 
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low as possible: Another very effective way of reducing radiation dose is the use of 
ECG-correlated tube current modulation 29, in which full tube current is limited to a short 
time period in diastole. In this way radiation dose is typically reduced by 30 to 40% 30. 
Tube current modulation is particularly effective in low heart rates. Furthermore, 
reducing tube voltage to 100 kV instead of the commonly used 100 kV results in a 
substantial further reduction of radiation exposure 31 and should be considered in 
patients with a low to moderate body mass.  
While the radiation dose of a cardiac CT scan is in the same order of magnitude 
as other diagnostic tests used in cardiology, such as nuclear perfusion scans (with a 
typical dose of 8 to 25 mSv 32, all possible measures should be taken to keep the dose 
as low as possible, and considerations as to clinical indications for cardiac computed 
tomography must always take radiation exposure into account 33.  
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3.  Coronary Artery Imaging 
Detection of Coronary Artery Stenoses  The opportunity to non-invasively 
visualize coronary anatomy is the major reason for the current interest in cardiac MDCT. 
In the year 2000, 4-slice CT systems for the first time allowed coronary artery imaging 
with spiral CT, but limited spatial and temporal resolution, as well as long scan times (up 
to 35 seconds) limited their clinical value for coronary artery visualization. Only the 
proximal parts of the coronary arteries were interpretable and up to 25% of coronary 
segments could not be evaluated due to insufficient image quality 1;3. With the 
introduction of 16- and 64-slice MDCT systems, improved temporal and spatial 
resolution as well as substantially shorter scan times led to improved image quality 
throughout the entire coronary tree (Figure 1). A recent meta-analysis demonstrated a 
significant improvement in the accuracy for the detection of coronary artery stenoses for 
64-slice CT as compared to previous scanner generations. The weighted mean 
sensitivity for the detection of coronary artery stenoses increased from 84% for 4-slice 
CT and 83% for 16-slice CT to 93% for 64-slice CT, while the respective specificities 
were 93%, 96%, and 96% 34.  
The results of recent studies that analyzed the accuracy of 64-slice CT for the 
detection of coronary artery stenoses in patients with suspected coronary artery disease 
(CAD) are summarized in Tables 1a and 1b. Pooling the data of more than 600 patients 
yields a sensitivity of 88%, a specificity of 96%, a positive predictive value of 79% and a 
negative predictive value of 98%. On average, 5.6% of segments (mainly distal 
segments or very small side-branches) could not be evaluated. Importantly, the 
negative predictive value was consistently high in all studies, indicating that the 
technique may be most suitable as a non-invasive tool to rule out the presence of 
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hemodynamically significant coronary stenoses and avoid further imaging or invasive 
angiography. 
However, it is important to realize that patient selection may still heavily influence 
results, with substantially impaired image quality in patients with higher heart rates or 
arrhythmias 10. Image quality may also be degraded in patients with severe CAD due to 
the presence of extensive calcifications which potentially limit precise assessment of the 
stenosis severity 35. Improvements can be expected from the introduction of dual-source 
computed tomography (DSCT) systems 36, which provide higher temporal resolution by 
employing 2 rotating x-ray tubes rather than one 37. Preliminary studies using this 
technique showed that up to 98% of all coronary segments could be visualized without 
motion artefacts, even without lowering the heart rate by administration of beta blockers 
5;38;39
. Moreover, even in patients without stable sinus rhythm, a high accuracy could be 
obtained and an initial, small study found a high accuracy for stenosis detection in 
patients with advanced CAD 40. 
In addition, 256-slice MSCT systems, whose large coverage along the z-axis 
(patient’s longitudinal axis) may allow imaging of the entire heart in a single cardiac 
cycle and will make coronary CT angiography less susceptible to arrhythmias or heart 
rate variability, will become available in the near future 41.  
 
Lesion severity and functional relevance  The limited temporal and spatial 
resolution of CT may create difficulties in accurately assessing the severity of coronary 
artery stenoses. There is a tendency to overestimate the degree of luminal narrowing by 
CT as compared to invasive angiography 42 and pronounced calcification of a vessel 
segment can make lesion assessment particularly difficult. Usually, calcification will lead 
to overestimation, rather than underestimation of lesion severity 43. Furthermore, 
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coronary CT angiography is limited to the anatomic visualization of stenoses and does 
not provide information as to the functional relevance of a lesion. In a recent head-to-
head comparison of MDCT and nuclear myocardial perfusion imaging with SPECT in 
114 patients with intermediate likelihood of CAD 44, only 45% of patients with an 
abnormal MDCT had abnormal perfusion on SPECT. Even in patients with obstructive 
lesions on MDCT, 50% still had a normal SPECT. These findings are in agreement with 
other preliminary reports 45-47 which showed that only a fraction of patients with 
obstructive coronary lesions demonstrate ischemia on SPECT and PET perfusion 
imaging.  
For this reason, while 64-slice MDCT is a reliable tool to rule out functionally 
relevant CAD in a non-selected population with an intermediate pre-test likelihood of 
disease, an abnormal coronary CT angiogram does not necessarily predict ischemia. In 
fact, since coronary CT angiography and perfusion imaging provide different and 
complementary information their sequential use or hybrid imaging may provide useful 
incremental information (Figure 2). In a recent study, hybrid PET/CT 48 was evaluated in 
patients with suspected CAD and yielded a sensitivity and specificity of 90% and 98%, 
respectively for the detection of hemodynamically relevant coronary lesions.  
Clinical Implications and Recommendations  Most of the accuracy data that is 
currently available concerning the detection of coronary stenoses by CT angiography 
has been obtained in patient groups with suspected CAD and stable symptoms. The 
consistently high negative predictive value in all studies suggests that CT angiography 
will be clinically useful test to rule out coronary stenoses in this patient group. In patients 
with a very high pre-test likelihood of disease, the use of CT angiography will most likely 
not result in a “negative” scan that would help avoid invasive angiography. Therefore, 
the use of CT angiography should be restricted to patients in whom symptoms and the 
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results of other testing (e.g., a stress test) suggest a low to intermediate pre-test 
likelihood of disease (Table 2) 49. Several authors have evaluated the accuracy of 
coronary CT angiography in specific clinical scenarios. Meijboom studied the diagnostic 
performance of 64-slice MDCT in patients referred for valve surgery 50. While about 
30% of patients had to be excluded to due arrhythmias or impaired renal function, the 
authors found a sensitivity of 100% (18/18), specificity of 92%, positive predictive value 
of 82% and negative predictive value of 100% (48 of 48) to identify patients with at least 
on relevant coronary stenosis and concluded that 64-slice MDCT was a reliable tool to 
rule out significant coronary stenoses in patients undergoing valve surgery. Other 
situations in which coronary CT angiography was shown to have a high accuracy for the 
detection of patients with CAD were patients with dilated cardiomyopathy (sensitivity of 
99%, specificity of 96%, and negative predictive value of 99). 51, and in patients with left 
bundle branch block (sensitivity 97%, specificity 95%, negative predictive value 97%) 7. 
Another clinically relevant group of  patients who often have a rather low likelihood of 
CAD, but who must undergo diagnostic stratification are those presenting with acute 
chest pain. Several trials have assessed the accuracy and clinical utility of coronary CT 
angiography in this setting. Hoffmann et al. conducted a blinded, prospective study in 
patients presenting with acute chest pain to the emergency department to rule out acute 
coronary syndrome with absence of ischemic ECG changes and negative initial 
biomarkers 52. Among 103 consecutive patients studied by 64 slice CT, 14 patients 
clinically were diagnosed to have an acute coronary syndrome (ACS). Both the absence 
of significant coronary artery stenosis (73 of 103 patients) and non-stenotic coronary 
atherosclerotic plaque (41 of 103 patients) accurately predicted the absence of ACS 
(negative predictive values of 100%). The authors concluded that the non-invasive 
assessment of CAD by MDCT had good performance characteristics for ruling out ACS 
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in subjects presenting with possible myocardial ischemia to the emergency department 
and may be useful for improving early triage. Goldstein et al. randomized 197 patients 
with low-risk acute chest pain to an immediate 64-slice CT scan  or “standard of care” 
evaluation 21. CT evaluation was safe, with no missed diagnosis of an acute coronary 
syndrome, faster (3.4 h vs. 15 h until establishing the definitive diagnosis) and had 
lower cost ($1586 vs. $1872). 
In summary, the clinical application of coronary CT angiography to detect or rule 
out coronary artery stenoses seems most beneficial and, according to current data, can 
be recommended in patients with low to intermediate risk of CAD in whom the clinical 
presentation - stable or with acute symptoms - mandates the evaluation of possible 
underlying CAD. The use of coronary CT angiography should be restricted to patients in 
whom diagnostic image quality can be expected (e.g., absence of arrhythmias) and 
scans need to be expertly performed and interpreted. 
 
Coronary Stent Imaging  Visualization of the lumen of coronary artery stents remains 
a challenge for MDCT due to metal artefacts caused by stent struts 53;54 (Figure 3). High 
rates of unevaluable stents have been reported in studies using 16-slice systems, 
ranging from 5% to 49% 55;56. With the more recently available 64-slice systems, in 
combination with dedicated reconstruction algorithms, a larger percentage of stents may 
be eligible for evaluation (Table 3) 57. 5 studies (with 382 patients and 504 stents) that 
have compared 64-slice CT to invasive angiography for the detection of in-stent 
stenosis are currently available. On average, 86% of stents were interpretable. 
Interpretable stents could be evaluated with fairly high diagnostic accuracy; weighted 
mean sensitivities and specificities were 89% and 94% respectively. While the negative 
predictive value was uniformly high (90%-99%), positive predictive values were as low 
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as 67%. For all scanner generations, the stent diameter has been identified as a major 
predictor of stent evaluability, with particularly low rates of evaluable stents for 
diameters of 3.0 mm or less 58. Patient weight, which determines image noise, and heart 
rate may also influence stent assessability.  
Clinical Implications and Recommendations  Given the difficulty of reliable stent 
visualization and the often low accuracy, routine application of MDCT to assess 
coronary stents can therefore currently not be recommended. 
 
Coronary artery bypass grafts  Coronary artery bypass grafts (CABG) move 
less rapidly and particularly venous grafts have relatively large diameters as compared 
to native coronary arteries (Figure 4). Occluded grafts and stenoses in the body of 
bypass conduits can therefore be detected with very high diagnostic accuracy 59-63. 
Clinically, it is important to consider that in most cases it will not be sufficient to assess 
only the grafts themselves. Much rather, the distal run off, as well as the non-grafted 
coronary arteries must be included in the evaluation. However, accurate assessment of 
the native coronary arteries by cardiac CT in patients after bypass surgery is often 
challenging and image quality impaired because of advanced CAD and pronounced 
coronary calcifications. Consequently, the few studies that have investigated the 
accuracy of CT angiography to evaluate the native arteries in patients with bypass 
grafts have reported low accuracies (Table 4) . Low positive predictive values were 
reported (44% in a recent publication using 64-slice CT), which severely limits the 
clinical utility of CT imaging in patients after bypass surgery 25. 
Clinical Implications and Recommendations  While the clinical application of CT 
angiography may be useful in very selected patients in whom only bypass graft 
assessment is necessary (e.g., failed visualization of a bypass graft in invasive 
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angiography), the inability to reliably visualize the native coronary arteries in patients 
post bypass surgery poses severe restrictions to the general use of CT angiography in 
post-bypass patients.  
 
Coronary artery anomalies  While coronary anomalies are rare conditions, 
possible consequences include myocardial infarction (MI) and sudden death 64. In 
young athletes, coronary artery anomalies are the second most common cause of 
sudden death due to structural heart disease 65. The identification of the origin and 
course of aberrant coronary arteries by invasive angiography can be difficult 66. 
Because of the three-dimensional nature of the data set, MDCT is very well suited to 
detect and define the anatomic course of coronary artery anomalies and their 
relationship to other cardiac and non-cardiac structures (Figure 5). Numerous case 
reports and several research papers have demonstrated that the CT analysis of 
coronary anatomy in these patients is straightforward and very reliable with an accuracy 
close to 100% 67-70.  
Clinical Implications and Recommendations  The robust visualization and 
classification of anomalous coronary arteries makes CT angiography a first-choice 
imaging modality for the investigation of known or suspected coronary artery anomalies. 
Radiation dose must be considered in the often young patients and measures to keep 
dose as low as in any way possible must be employed. 
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4. Coronary Plaque Imaging 
Calcium Scoring  Coronary calcium is a surrogate marker for the presence and 
amount of coronary atherosclerotic plaque 71;72. Both Electron Beam Computed 
Tomography and Multi-Detector CT allow the accurate detection and quantification of 
coronary artery calcium 72;73. The radiation dose for a calcium scan is in the range of 1-2 
mSv 74;75. The so-called “Agatston Score”, which takes into account the area and the CT 
density of calcified lesions, is most frequently used to quantify the amount of coronary 
calcium in CT and large population reference data bases are available. With the 
exception of patients with renal failure, calcifications occur exclusively in the context of 
atherosclerotic lesions 71;72;76.  
The amount of coronary calcium correlates moderately closely to the overall 
atherosclerotic plaque burden 77. On the other hand, not every atherosclerotic coronary 
plaque is calcified and calcification is neither a sign of stability nor of instability of an 
individual plaque 78. Clinically, coronary calcium is detectable in the vast majority of 
patients with acute coronary syndromes, and the amount of calcium in these patients is 
substantially greater than in matched control subjects without CAD 79-82.  
In several trials, the absence of coronary calcium ruled out the presence of 
significant coronary artery stenoses with high predictive value 76;77. However, even 
pronounced coronary calcification is not necessarily associated with hemodynamically 
relevant luminal narrowing. Therefore, even the detection of large amounts of calcium 
does not indicate the presence of significant stenoses and it should not prompt invasive 
coronary angiography in otherwise asymptomatic individuals. 
Numerous prospective trials have demonstrated that the presence of coronary 
calcium in asymptomatic individuals is a prognostic parameter with strong predictive 
power for future hard cardiac events 76;77;83-86. All the same, patient management 
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approaches based on calcium assessment have not been prospectively investigated. A 
beneficial contribution of coronary calcium assessment to risk stratification can most 
likely be expected in individuals who seem to be at intermediate risk for coronary events 
(0.6-2.0 percent annual risk) based on traditional risk factor analysis. Unselected 
“screening” or patient self-referral is uniformly not recommended 76;77;87. 
While the coronary calcium score has been found to be progressive over time, 
only very preliminary studies are available that have linked progression of coronary 
calcium to cardiac event rates 88. Results concerning the influence of lipid-lowering 
therapy on the progression of coronary calcium have been inhomogeneous 76;83;89-92. In 
addition, the variability of coronary calcification measurements is high. Therefore, there 
is no current indication for repeated coronary calcium score measurements 76;77;87. 
Clinical Implications and Recommendations The use of coronary calcium 
measurements by CT seems most beneficial in patients who, based on prior 
assessment of standard risk factors, seem to be at intermediate risk for future CAD 
events and in whom more information is needed to make a decision on intensifying risk 
factor modification (e.g., initiation of lipid lowering therapy). Patients at high risk do not 
need further stratification, and in patients at obviously low risk the likelihood of finding 
coronary atherosclerosis is too low to warrant computed tomography imaging. Usually, 
“intermediate risk” patients in whom the use of coronary calcium is assumed to provide 
incremental information are those with a 10-year PROCAM or Framingham Risk 
between 5 and 20% 76;77.  
 
Non-calcified plaque There is growing interest concerning the ability of contrast-
enhanced CT coronary angiography to detect (and possibly to quantify and to further 
characterize) non-calcified coronary atherosclerotic plaque 93 (Figure 6). Data on the 
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accuracy of CT angiography to detect non-calcified plaque is limited to a small number 
of studies that have compared CT angiography to intravascular ultrasound (IVUS). 
Sensitivities for the detection of coronary segments with plaque were found to be 
approximately 80% to 90% (which, however, was mostly based on the detection of 
calcified plaque) 94-97. Correlation of plaque area (r = 0.55) and plaque volume (r = 0.83) 
between CT angiography and IVUS was found to be moderate, and interobserver 
variability is high 96;98. It has been shown that the extent of remodelling of coronary 
atherosclerotic lesions can be assessed by CT 99. Some data is available concerning 
plaque characterization by CT: On average, the CT attenuation within „fibrous“ plaques 
is higher than within „lipid-rich“ plaques (mean attenuation values of 91-116 HU versus 
47-71 HU)95;96;100-106, but there is large variability of these measurements, which 
currently prevents accurate classification of non-calcified “plaque types” by CT 105.  
Prognostic data that would support clinical applications of plaque imaging by 
contrast-enhanced CT are scarce 107. As opposed to coronary calcium assessment, no 
prospective trials have investigated the predictive value of non-calcified plaque in large 
groups of individuals. Preliminary retrospective, small studies with 23 to 46 participants 
have used CT to investigate plaque characteristics in patients after acute coronary 
syndromes in comparison to patients with stable angina. They reported a higher fraction 
of non-calcified plaque and more positive remodelling in patients with acute coronary 
syndromes and in lesions responsible for cardiac events 108-111. One study found a 
significantly higher prevalence of plaque with a CT attenuation below 30 HU in lesions 
associated with acute coronary syndromes as compared to stable lesions 112. One 
analysis of 100 patients who were followed for 16 months after coronary CT 
angiography demonstrated a higher cardiovascular event rate in patients with non-
obstructive plaque detected by MDCT as compared to individuals without any plaque 
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113
. While these initial observations suggest that there may be a potential value of 
plaque imaging by CT coronary angiography for risk prediction, one must be aware that 
reliable visualization of coronary plaque requires the highest possible image quality 
which goes along with substantial expenses in radiation and contrast agent exposure. 
The use of CT angiography for risk stratification will therefore only be clinically indicated 
after a substantial advantage over other methods for risk prediction has been clearly 
demonstrated.  
Clinical Implications and Recommendations  The fact that there is currently a 
lack of prospective clinical data that would support the use of contrast-enhanced CT 
angiography for the assessment of non-stenotic plaque does not allow clinical 
applications in asymptomatic individuals for the purpose of risk stratification. However, 
the tremendous potential of CT angiography for visualization and characterization of 
coronary plaques must be recognized and further research is strongly supported. 
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5. Non-coronary Imaging 
 
Left and right ventricular function  On commercially available workstations, 
functional parameters such as left and right ventricular end-diastolic and end-systolic 
volumes, stroke volume, ejection fraction and myocardial mass can be calculated from 
cardiac CT angiography data sets (Figure 7). Various studies have shown that for these 
left ventricular functional parameters, MDCT correlated well with magnetic resonance 
imaging, echocardiography or gated SPECT 114-118. Some studies found a systematic 
over- or underestimation of left ventricular volumes determined by CT as compared to 
the reference method. Most likely, these were due to inaccuracies in defining end-
systolic or end-diastolic time instants. The magnitude of these differences was uniformly 
too small to be of clinical relevance.  
Assessment of right ventricular function and volumes using MDCT has also been 
validated and found to be accurate in comparative studies with echocardiography 119, 
and equilibrium radionuclide ventriculography 120, in patients with various abnormalities 
including pulmonary embolism 121, congenital heart disease 122, and atrial septal defect 
123
.  
Clinical Implications and Recommendations While CT imaging obviously allows 
accurate assessment of left and right ventricular function, CT exams will in most cases 
not be performed specifically for that purpose. Other diagnostic tests without radiation 
exposure or the need for contrast injection (most prominently, echocardiography) are 
the methods of choice. It should be noted, however, that the ventricular function is 
adjunct information that can be obtained from standard coronary CT angiography 
investigations without altering the image acquisition protocol. 
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Myocardial viability and perfusion Several preclinical and clinical studies have 
documented that MDCT allows assessment of myocardial viability by studying “late 
enhancement” in a similar fashion as magnetic resonance imaging 124-130. In the setting 
of acute, subacute, and chronic myocardial infarction (MI); myocardial perfusion defects 
can be observed during the early phase of the contrast bolus (“early defect”). 
Subsequently, 5-15 minutes following contrast infusion, late hyper-enhancement of 
infarcts becomes apparent (Figure 8). Lardo et al. 129 demonstrated excellent 
agreement of infarct size in the setting of acute MI and chronic myocardial scar in 
preclinical animal models of MI compared with gross pathology and these results were 
confirmed more recently by Brodoefel et al.125. Similar results were demonstrated by 
Gerber et al. in 16 patients with acute MI and 21 patients with chronic MI 127. Mahnken 
et al. studied 28 patients in the setting of reperfused MI and demonstrated that 
compared with magnetic resonance imaging, early defects tend to underestimate infarct 
size in MDCT, while late-enhancement shows excellent agreement in infarct size and 
location 130. While these results appear promising, magnetic resonance remains the 
non-invasive gold standard to assess the size of myocardial scars, and myocardial 
structure. 
Furthermore, there is preclinical and preliminary clinical evidence that contrast-
enhanced MDCT can provide assessment of myocardial perfusion. As a complement to 
the morphologic information of CT coronary angiography, the assessment of myocardial 
perfusion might be of clinical utility. George et al. demonstrated in an animal model of 
coronary stenosis that MDCT angiography protocols, when performed during adenosine 
infusion, can provide semi-quantitative measures of myocardial perfusion 131. 
Preliminary clinical evidence suggests that this same method, when applied to patients 
at high risk for CAD, may be capable of detecting early perfusion deficits in myocardial 
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territories supplied by vessels with obstructive atherosclerosis. The high spatial 
resolution of MDCT also allows for the assessment of the subendocardial distribution of 
myocardial ischemia. Limitations of this technique include adenosine-mediated 
tachycardia, attenuation- and motion artefacts.  
Clinical Implications and Recommendations  Clinical data is currently too limited 
to allow clinical recommendations on the use of CT for assessment of perfusion and 
viability.  
 
Valvular disease  The assessment of aortic valve stenosis using multi-slice computed 
tomography is feasible with good diagnostic accuracy 132-136 (Figure 9). Rather than 
relying on gradients, MDCT allows direct planimetry of the aortic valve area. Feuchtner 
et al. compared 16-slice MDCT to transthoracic echocardiography (TTE) in 30 patients 
with aortic valve stenosis 135. The sensitivity of MDCT for the identification of patients 
with aortic stenosis was 100%, and specificity was 93.7%. Quantification of the aortic 
valve area by MDCT revealed a good correlation with TTE (r=0.89; p<0.001). Similarly, 
in 20 patients with aortic valve stenosis, Alkadhi et al. 132 reported an excellent 
correlation between the planimetrically assessed aortic valve areas in CT and 
transesophageal echocardiography.  
It is important to note that the use of ECG-correlated tube current modulation, 
which is usually used in coronary CT angiography to limit overall radiation exposure to 
the patient, may interfere with reliable assessment of the aortic valve. Tube current 
modulation reduces the tube current in systole and may thus prohibit high-resolution 
imaging of the open aortic valve. 
The accuracy to detect and quantify aortic valve regurgitation in comparison to 
TTE has also been investigated by Feuchtner et al. 134. When a visible valvular leakage 
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area was considered to be a diagnostic criterion for aortic regurgitation, the overall 
sensitivity of 16-slice MDCT for the identification of patients with aortic regurgitation was 
81% with a positive predictive value of 95%. However, severe calcifications – which are 
more common in degenerative valvular disease – limited the diagnostic accuracy. In 
another study including 64 patients, planimetry of the diastolic regurgitant orifice area 
using 64-slice MDCT was compared to TTE 137. In 34 age-matched controls no 
regurgitant orifice was found, while in all 30 patients regurgitation was correctly 
diagnosed. These findings suggest that MDCT permits reliable assessment of aortic 
valve stenosis and regurgitation.  
Willmann et al.138 published data from patients with mitral valve disease in whom 
MDCT was performed. The authors found MDCT helpful for detection of valvular 
abnormalities like thickening of the mitral valve leaflets, presence of mitral annulus 
calcification, and calcification of the valvular leaflets. Agreement with echocardiography 
was achieved in 95 to 100% of cases. Alkadhi et al. 139 demonstrated that 16-slice 
MDCT allowed visualization of a regurgitant orifice in all 19 patients with mitral 
regurgitation. The mean regurgitant orifice area on MDCT was significantly related to 
the TEE-based assessment of regurgitation severity (r=0.81, p<0.001). Thus, MDCT 
seems to have the potential to visualize coaptation defects of the mitral leaflets.  
Clinical Implications and Recommendations  CT imaging may develop into an 
alternative imaging tool in patients who require exact assessment of the opening or 
regurgitant orifice of the aortic or mitral valve and in whom other more commonly used 
methods, such as echocardiography and magnetic resonance imaging fail to provide all 
relevant information. Currently, available clinical data are too limited to allow 
identification of specific patient subsets in which CT imaging would be the first choice 
diagnostic test. 
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Venous anatomy Anatomy of the coronary venous system can be accurately 
assessed with MDCT 140;141. Recently, Van de Veire et al.142 demonstrated that the 
variability in venous anatomy may be related to previous infarction with formation of 
scar tissue. In 34 patients with a history of MI, the left marginal vein was less frequently 
observed compared to control patients and patients with CAD (27% vs. 71% and 61%, 
respectively, p<0.001). The absence of a left marginal vein in these patients may 
hamper the positioning of a left ventricular lead for cardiac resynchronization therapy if 
necessary. In this respect, MDCT may be a valuable tool for the non-invasive 
assessment of coronary venous anatomy before the implantation of a left ventricular 
lead or other interventions that make use of the cardiac veins.  
Clinical Implications and Recommendations Even though there is currently 
rather limited data, exact anatomy of the coronary veins cannot be obtained with 
imaging methods other than cardiac CT. If such information is desired, contrast-
enhanced CT imaging will be a test of choice.  
 
Left atrial and pulmonary vein anatomy CT imaging allows accurate imaging of 
the anatomy of both atrial and pulmonary venous return and in this context, the role of 
MDCT in performing electrophysiological procedures such as catheter ablation has 
rapidly expanded over the past few years 143-145. Radiofrequency catheter ablation 
procedures are performed in an increasing number of patients with drug-refractory atrial 
fibrillation. MDCT can provide a detailed ‘roadmap’ for these ablation procedures by 
visualizing the highly variable pulmonary vein anatomy with the use of volume-rendered 
three-dimensional reconstructions and cross-sectional images (Figure 10). Anatomical 
variations in pulmonary vein anatomy include a single insertion or ‘common ostium’ of 
the pulmonary veins, and an additional pulmonary vein. In 201 patients undergoing 
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MDCT scanning, Marom et al. noted a left-sided “common ostium” in 14% of the 
patients, and an additional right-sided pulmonary vein in 28% of the patients. By 
delineating surrounding structures such as the aorta, coronary arteries and the 
oesophagus, MDCT is of great value to avoid complications during the ablation 
procedure. 
Recently it has become feasible to integrate the anatomical information derived 
from MDCT with the electroanatomical information from cardiac mapping systems to 
plan radiofrequency ablation of complex cardiac arrhythmias 146;147. These image 
integration systems allow the use of ‘real’ anatomy derived from MDCT during the 
actual ablation procedure (Figure 11). By visualizing the catheter position in relation to 
the endocardial border, the pulmonary veins and surrounding structures, performing 
catheter ablation procedures may be facilitated. Initial data indicate that the use of these 
image integration systems may enhance safety and improve the outcome of ablation 
procedures for atrial fibrillation 148. In addition, MDCT is important in the follow-up of 
patients after catheter ablation procedures. The use of MDCT in the identification of 
pulmonary vein stenosis after catheter ablation has been described extensively 149-151 
and MDCT is an inherent part in the care of these patients.  
Clinical Implications and Recommendations: No firm clinical indications exist 
currently and further research is needed to establish the position of MDCT in clinical 
electrophysiology. 

Congenital heart disease Patients with congenital cardiovascular disease are 
frequently examined invasively and non-invasively to assess coronary anatomy and 
morphological as well as functional parameters. Because of the high spatial and 
temporal resolution, the comfortable post-processing tools and the rapid image 
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acquisition, MDCT has become an important non-invasive diagnostic examination both 
in children and adults with congenital heart disease 152;153. 
MDCT is a valuable tool in the pre-operative evaluation of cardiac anomalies 
(such as tetralogy of Fallot), and the follow-up of baffles and shunts. In addition, patients 
with untreated patent ductus arteriosus or coarctation of the aorta and patients with 
anomalous pulmonary venous return can be evaluated accurately with MDCT 154. 
Furthermore, MDCT can depict coronary artery anatomy, which is often anomalous in 
patients with congenital heart disease. Cook et al. evaluated the MDCT data sets of 85 
patients with congenital cardiovascular disease 155. The relationship of the great 
vessels, number and location of the coronary ostia, and proximal course of the 
coronaries could be identified in all cases and coronary anomalies were detected in 16 
of the 85 patients.  
Clinical Implications and Recommendations Although MDCT provides detailed 
anatomic information, which is of major importance in the care of patients with 
congenital heart disease, it has to be taken into account that exposure to radiation 
during follow-up of these patients mainly stems from CT scans and angiography 156. In 
particular when serial evaluation over time is needed, non-ionizing imaging procedures 
(such as magnetic resonance imaging and echocardiography) should be considered. 
On the other hand, MDCT scanning is not hampered by the presence of pacemakers 
and metal artefacts and therefore may be indicated in patients with implanted devices if 
echocardiography does not provide all clinically necessary information.
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6. Performing Cardiac CT in Clinical Practice 
Training  Cardiac CT imaging requires competence on many levels: Data 
acquisition needs to be carefully performed, including necessary premedication, and 
appropriate measures have to be taken to keep radiation exposure in a reasonable 
range. Image reconstruction and post-processing require knowledge in CT physics, 
radiology, as well as cardiac physiology (e.g., for detecting arrhythmias, editing ECG 
traces and identifying optimal cardiac phases). Finally, competent image interpretation 
must be based on knowledge and experience in CT angiography, as well as detailed 
knowledge of cardiac anatomy, normal and variant patterns of the coronary circulation, 
and a thorough clinical background in CAD. Obviously, neither conventional training in 
Radiology nor in Cardiology will “per se” provide a sufficient background to perform and 
evaluate cardiac CT imaging. Current fellowship training programs do not incorporate 
mandatory exposure to cardiac CT at a volume that would suffice to provide competent 
diagnostic services in cardiac CT. 
  In the United States, guidelines have been issued by professional societies that 
address minimum requirements in order to obtain competency in cardiac CT imaging 
157
. In a statement on non-invasive cardiac imaging published by the American College 
of Radiology in 2005, the qualification of a radiologist who supervises and interprets 
cardiac CT examinations should include supervision and interpretation of 75 cardiac CT 
cases within 36 months, excluding cases performed exclusively for calcium scoring 158.  
In 2006, the American College of Cardiology and American Heart Association issued a 
joint statement concerning competency in cardiac CT imaging. Minimum requirements 
for competency in cardiac CT have been defined for 3 levels of proficiency (Table 5) 157. 
Briefly, for coronary CT angiography, “Level 1” defines a basic knowledge of cardiac 
CT, which is sufficient for practice of general adult cardiology or general radiology, but 
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not for independent interpretation of patient data sets. It requires 4 weeks of training as 
well as hands-on interpretation of 50 cases of CT coronary angiography. “Level 2” 
training defines the minimum recommended experience in order to independently 
perform and interpret CT coronary angiography. “Level 2” training requires a cumulative 
duration of 8 weeks of training, mentored performance of 50 contrast-enhanced and 50 
non-contrast scans, and hands-on interpretation of 150 contrast-enhanced cardiac CT 
data sets. “Level 3” training would qualify an individual to direct an independent cardiac 
CT program. It requires 6 months of training, 100 cases performed and 300 cases 
interpreted, plus 40 hours of Continuing Medical Education. 
  No scientific data exists on the required amount of training to achieve a certain 
level of diagnostic confidence in cardiac CT and the published recommendations are a 
consensus-based compromise between what is deemed necessary and possible. While 
specific numbers are suggested, some issues remain open, such as the question what 
exactly constitutes a “mentored examination”: Taped video documentation of a scanning 
procedure may be adequate for a certain percentage of these cases, but not for all of 
them, and many details are up to interpretation.  
  Eventually, similar guidelines will need to be developed for other countries, and 
ultimately, Fellowship training in cardiology will need to incorporate sufficient exposure 
to cardiac CT, along with appropriate verification of knowledge.  
 
Cost effectiveness and reimbursement  Data on accuracy, prognostic 
implications, and cost-effectiveness must form the basis for establishing reimbursement 
for cardiac CT imaging. Currently, very little data that firmly establish prognostic 
implications of CT coronary angiography and little data on cost-effectiveness in relation 
to established diagnostic procedures are available. Initial studies in two of the most 
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promising applications of cardiac CT, the use of CT angiography in patients with stable 
chest pain and the use of CT in patients who present to the emergency room with chest 
pain indicate potential cost advantages for CT imaging over established, conventional 
diagnostic algorithms.  
Dewey et al. compared the cost of CT angiography, stress magnetic resonance 
imaging and traditional diagnostic modalities, which encompassed exercise ECG, stress 
echocardiography, and conventional angiography 159. They could show that for a pretest 
probability up to 50%, CT coronary angiography (with costs of €1469 to €4435) was 
most cost-effective. For pretest likelihoods exceeding 60%, invasive angiography was 
most cost-effective. 
Goldstein et al. analyzed cost-effectiveness in their study of 197 patients 
admitted to the emergency room for acute chest pain but who were deemed at low risk 
for CAD 21. They found that incorporation of coronary CT angiography into the workup 
was not only safe (no patient with acute coronary syndrome was missed by CT), but in 
addition, a diagnostic algorithm based on CT was more rapid (3.4 hours versus 15.0 
hours, p < 0.001) and less costly ($1856 vs. $1872, p < 0.001) than a standard 
diagnostic algorithm based on repeat ECG and blood testing as well as stress perfusion 
imaging. 
Cost effectiveness analyses must, of course, be much more elaborate than these 
two initial studies, and they will vary strongly from country to country. Such analyses 
substantially depend on the absolute cost of various procedures in the respective 
country, and on the relative rates of reimbursement assigned to diagnostic tests.  
Reimbursement of cardiac CT is currently inhomogeneous between countries 
and often even between health insurance carriers within a given country. In most 
countries, there is no specific reimbursement for cardiac CT procedures: If 
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reimbursement is established, it should be taken into account that performing and 
evaluating a cardiac CT scan requires more dedicated effort than a standard chest CT 
scan (e.g., the need for premedication, ECG gating, dedicated reconstructions at 
various cardiac phases), which needs to be reflected by the reimbursement structure. 
Clearly, adequate reimbursement - possibly tied to stringent guidelines on specific 
clinical situations in which cardiac CT is useful - will be necessary to allow more 




The most recent generations of MDCT allow for robust morphologic and functional 
imaging of the heart. Clinically, the main focus of cardiac CT is coronary artery imaging. 
The assessment of coronary anomalies by coronary CT angiography is straightforward 
and CT is indicated for that purpose. Under certain prerequisites - which include a low 
and regular heart rate - a carefully performed coronary CT angiography investigation 
allows for the accurate detection of coronary artery stenoses. Especially the negative 
predictive value has uniformly been found to be high, indicating that the technique may 
be most suitable as a non-invasive tool to rule out the presence of hemodynamically 
significant coronary stenoses. Based on clinical considerations and initial clinical trials, 
this may be of particular utility in situations that require to reliably rule out CAD even 
though the pre-test likelihood for disease is not high, such as patients with atypical 
chest pain, patients with equivocal stress test results, patients with acute chest pain in 
the absence of ECG changes or enzyme elevations, or patients before non-coronary 
cardiac surgery. In these situations, the rationale for using CT is to achieve more rapid 
and definitive stratification and to avoid invasive coronary angiography if CT 
demonstrates the absence of stenoses. In patients with a high pre-test likelihood of 
disease, however, the use of CT angiography will most likely not result in a “negative” 
scan that would help to avoid invasive angiography and is therefore not 
recommendable.  
Several situations currently pose challenges for reliable CT imaging. This 
includes patients with arrhythmias, patients with advanced coronary disease and 
pronounced coronary calcification, and patients with implanted coronary artery stents 
that are often difficult to evaluate. Similarly, while coronary artery bypass grafts can be 
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assessed with very high diagnostic accuracy, detection of stenoses at the site of 
anastomosis and in the native coronary arteries of patients after bypass surgery has 
reduced accuracy. Coronary CT angiography is not routinely recommendable in these 
situations.  
 Besides the detection of coronary stenoses, cardiac CT has the potential to 
visualize earlier stages of coronary atherosclerosis. Coronary calcium, a surrogate 
marker for the presence and amount of coronary atherosclerotic plaque, can be 
detected and quantified by non-contrast CT. Coronary calcium allows to stratify 
asymptomatic individuals concerning their future cardiovascular risk with a predictive 
power that is stronger than and independent of traditional cardiovascular risk factors. 
The use of coronary calcium measurements by CT is generally considered useful in 
patients who, based on prior assessment of standard risk factors, seem to be at 
intermediate risk for future CAD events and may be appropriate in order to facilitate a 
decision concerning lipid-lowering therapy or other risk factor modification. Contrast-
enhanced coronary CT angiography allows the detection and, to a certain degree, the 
characterization of non-calcified coronary atherosclerotic plaque. However, clinical data 
concerning the accuracy of plaque detection and characterization by contrast-enhanced 
CT, as well as its prognostic significance are currently insufficient, so that applications 
for risk stratification can currently not be recommended.  
Besides assessment of the coronary arteries, CT provides for accurate 
assessment of general cardiac morphology. This can be particularly useful in the 
context of electrophysiology when detailed anatomic information e.g., of the pulmonary 
veins and left atrium (for ablation procedures) or coronary veins (for biventricular lead 
placement) is needed. Similarly, CT imaging can be useful in patients with congenital 
heart disease or other structural cardiac disease, especially when echocardiography 
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does not provide sufficient information and magnetic resonance imaging cannot be 
performed (e.g., in the presence of intracardiac devices). While information on flow 
velocities and intracardiac pressures cannot be obtained by CT; assessment of right 
and left ventricular function is accurate. The aortic and mitral valve can be depicted 
throughout the cardiac cycle and their orifice areas can be measured. Early data also 
indicates that “late enhancement” imaging of the myocardium is possible. However, for 
neither of these questions, CT imaging will usually be used as a first line diagnostic 
modality because of the associated contrast agent and radiation exposure. 
 While clinical application of cardiac CT is possible today in the situations outlined 
above, it can be expected that technology will continue to evolve rapidly. Spatial and 
temporal resolution will increase further, current indications as well as cost-
effectiveness will be more firmly established by large clinical trials, and new applications 
will be developed. In addition, it will be necessary to establish adequate training 
programs for cardiac CT, and to develop reimbursement structures which, tied to 
stringent guidelines on specific clinical situations for which cardiac CT is considered 
appropriate, will be necessary to allow more widespread use of computed tomography 
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Table 1 a. Diagnostic performance of 64-MDCT for detection of significant coronary 
stenosis (luminal diameter > 50%): Segmental analysis 
Table 1 b.  Diagnostic performance of 64-MDCT for detection of significant coronary 
stenosis (luminal diameter > 50%): Patient-based analysis 
Table 2. Appropriate indications for cardiac CT coronary angiography  
Table 3.  Detection of In-Stent-Restenosis using MDCT 
Table 4. Diagnostic accuracy of MDCT in the evaluation of bypass grafts, as well as 
of the native coronary arteries  
Table 5. Requirements for performing and interpreting cardiac CT 
 
Figure 1. Stenosis detection with MDCT  
Figure 2.  Hybrid Imaging  
Figure 3. Assessment of Coronary Artery Stents by Coronary CT angiography 
Figure 4.  Bypass Imaging 
Figure 5. Imaging of Coronary anomalies 
Figure 6. Plaque imaging with MDCT 
Figure 7. Assessment of Left Ventricular Function and Volumes 
Figure 8. Assessment of perfusion and viability 
Figure 9.  Assessment of Heart Valve Disease by MDCT 
Figure 10. Assessment of pulmonary veins by MDCT 
Figure 11. Fusion Imaging in Electrophysiology 
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Table 2. Appropriate indications for cardiac CT coronary angiography and cardiac CT  
  according to Hendel et al.  49 
 
Detection of CAD: Symptomatic—Evaluation of Chest Pain Syndrome (Use of CT 
Angiogram) 
 Intermediate pre-test probability of CAD 
 ECG uninterpretable OR unable to exercise 
 Intermediate pre-test probability of CAD 
 ECG uninterpretable OR unable to exercise 
Detection of CAD: Symptomatic—Evaluation of Intra-Cardiac Structures (Use of CT 
Angiogram) 
 Evaluation of suspected coronary anomalies 
Detection of CAD: Symptomatic—Acute Chest Pain (Use of CT Angiogram) 
 Intermediate pre-test probability of CAD 
 No ECG changes and serial enzymes negative 
Detection of CAD With Prior Test Results-Evaluation of Chest Pain Syndrome (Use of 
CT Angiogram) 
 Uninterpretable or equivocal stress test (exercise, perfusion, or stress echo) 
Structure and Function—Morphology (Use of CT Angiogram) 
 Assessment of complex congenital heart disease including anomalies of coronary 
circulation, great vessels, and cardiac chambers and valves 
 Evaluation of coronary arteries in patients with new onset heart failure to assess etiology 
Structure and Function—Evaluation of Intra- and Extra-Cardiac Structures (Use of 
Cardiac CT) 
 Evaluation of cardiac mass (suspected tumor or thrombus) 
 Patients with technically limited images from echocardiogram, CMR, or TEE 
 Evaluation of pericardial conditions (pericardial mass, constrictive pericarditis, or 
complications of cardiac surgery) 
 Patients with technically limited images from echocardiogram, CMR, or TEE 
 Evaluation of pulmonary vein anatomy prior to invasive radiofrequency ablation for atrial 
fibrillation 
 Non invasive coronary vein mapping prior to placement of biventricular pacemaker 
 Non invasive coronary arterial mapping, including internal mammary artery prior to repeat 
cardiac surgical revascularization 
Structure and Function—Evaluation of Aortic and Pulmonary Disease (Use of CT 
Angiogram 
 Evaluation of suspected aortic dissection or thoracic aortic aneurysm 
 Evaluation of suspected pulmonary embolism 
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Table 3. Available studies using 64-slice MDCT to evaluate in-stent restenosis 
Author Patients Stents* Assessable Sensitivity Specificity PPV NPV 
Rixe 58 64 102 58% 86% 98% 86% 98% 
Rist160 25 46 98% 75% 92% 67% 94% 
Oncel161 30 39 100% 89% 95% 94% 90% 
Ehara 18 81 125* 88% 91% 93% 77% 98% 
Cademartiri# 182 192 93% 95% 93% 63% 99% 
Total 382 504 86% 89% 94% 76% 98% 
• or stented lesions. #  JACC in press 
PPV: Positive Predictive Value, NPV: Negative Predictive Value 
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Table 4.  Diagnostic Accuracy of MDCT for the Evaluation of Bypass Grafts, as well  
  as of the Native Coronary Arteries  




  Pts./Grafts  Collimation/Rotation   Evaluation     Sensitivity   Specificity    n.e. 
 
Nieman162  24/86               4x1.0/500 ms   Graft-Patency        100% 98%    0%/5% 
       Graft-Stenosis    60%/83%    88%/90%  5%/10% 
       Native Arteries    79%/89%   72%/75%  31%/34% 
 
Stauder 163 20/ 50  12x0.75/420 ms Graft-Patency        100% 100%  --- 
Graft-Stenosis         98%    95%  12% 
       Native Arteries         92%             77%  31% 
 
Burgstahler164 13/43  16x0.75/375 ms Graft-Patency       100% 100%    --- 
       Graft-Stenosis      100%  93%         5% 
       Native Arteries       83%  59%       32% 
 
Salm165  25/67            16x1.0/400-500 ms Graft-Patency       100% 100%  --- 
       Graft-Stenosis      100%             94%         8% 
Native Arteries*    100%          89%           24% 
     
Malagutti 166 52/109   64x0.75/330 ms  Graft-Patency        98%           98%             ---
       Graft-Stenosis      100%              98%         2%
       Native Arteries     89%/97%     93%/86%     25% 
 
Ropers 25 50/138   64x0.75/330 ms Graft-Patency        100%   100%   --- 
Graft-Stenosis        100%              94%   --- 
Native Arteries     86%/86%    76%/90%     7%/9% 
 
 
Sensitivities and specificities are referred to evaluable bypass grafts/coronary segments. * evaluation was 
restricted to non-grafted vessels only. Pts: number of patients, n.e. = not evaluable. 
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Table 5. Requirements for performing and interpreting cardiac CT according to a 




Cumulative Duration of 
Training 
Minimum Number of Mentored 
Examinations Performed 
Minimum Number of Mentored 
Examinations Interpreted 
Level 1 4 weeks -- 50 
Level 2 - non-contrast 4 weeks 50 150 
Level 2 - contrast 8 weeks 50 150 














High-grade stenosis of the mid right coronary artery In a 55 year old male patient with 
atypical chest pain. 1a shows a maximum intensity projection, with a high grade luminal 
reduction distal to a calcified segment. 1b shows a “curved multiplanar reconstruction”. 1c 
shows a 3-dimensional rendering of the heart and right coronary artery. 1d shows the 
corresponding coronary angiogram obtained 3 days later. 
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Figure 2. Hybrid Imaging 
 
 
Hybrid imaging of MDCT coronary angiography and PET perfusion during adenosine 
stress. 3D rendered image of anterior view of the heart. In MDCT obstructive plaques were 
detected in the proximal segment of LAD and in the first diagonal branch. However, only in 
the myocardial region supplied by diagonal branch myocardial perfusion was reduced 
while in other regions preserved perfusion was detected. 
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Stent placed in the proximal part of the left anterior descending artery without significant 
in-stent-stenosis. A: longitudinal view, B: axial orientation, C: multiplanar reformation. 
A B C 
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Cardiac CT evaluation of the heart in an 82-years old male patient 9 years after bypass 
surgery. The curved multiplanar reconstruction (left side) of the venous graft to the first 
obtuse marginal branch demonstrates a significant lesion in the proximal part (arrow), 










a. Three-dimensional MDCT reconstruction (SENSATION 64, Siemens Medical Solutions, 
Forchheim, Germany) of a right-sided single coronary artery with a prepulmonary course 
of the left main stem in a 42-year old male patient. The left main (black arrows) is 
originating from the proximal part of the right coronary artery (black arrowheads; left side) 
than following a prepulmonary course to the anterior interventricular groove, where the left 
main splits in the left anterior descending coronary angiography (LAD), an intermediate 
branch (RIM) and the circumflex coronary artery (RCX, right side). Ao = Ascending Aorta. 


















b. Transaxial (slice thickness 5 mm) MDCT image (SENSATION 64, Siemens Medical 
Solutions, Forchheim, Germany) of a right-sided single coronary artery with an interarterial 
path of the left main stem in a 64-year old male patient. The left main (arrowheads) 
originates from the proximal part of the right coronary artery (black arrow) than following 
an interarterial path between the ascending aorta and the pulmonary trunk. The white 
arrows indicate the mid part of the circumflex coronary artery. Ao = Ascending aorta.; LA = 










Plaque imaging (maximum intensity projection) with multi-slice computed tomography 
showing an intermediate lesion in segment 2 of the right coronary artery (marked with an 
arrow), consisting of solely non-calcified plaque.   
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Figure 7.  Assessment of Left Ventricular Function and Volumes 
 
 
Left ventricular volumes calculated by tracing endocardial contours of standardized 
reformats in end-systolic and end-diastolic short- and long-axis view are comparable for 
SPECT (A) and 64-slice MDCT (B).  
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First-pass and delayed enhanced MDCT myocardial imaging in a porcine model of sub-
acute myocardial infarction. Panel A demonstrates an “early defect” in the anterior wall 
(arrows) during first-pass of the contrast bolus.  Panel B demonstrates a hyper enhanced, 
“late defect” in the anterior myocardial wall imaged 10 minutes following contrast infusion.   
A B
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Aortic valve morphology assessed by computed tomography. Upper row: Normal aortic 
valve, lower row: severely calcified aortic valve with aortic stenosis (right side: diastolic 
phase, left side: systolic phase of the heart cycle). 
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Figure 10.  Imaging of the Pulmonary Veins 
 
 
Anatomical variation of the pulmonary veins: a single insertion or ‘common ostium’ of the 
left-sided pulmonary veins is present. The veins drain come together before they drain in 
the left atrium (indicated by the black arrow). This is clearly depicted in the different 
orthogonal views (panel A, B, C) and the volume-rendered reconstruction (panel D). 
LA = left atrium, LIPV = left inferior pulmonary vein, LSPV = left superior pulmonary vein. 
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Figure 11.  Fusion Imaging in Electrophysiology 
 
 
Integration of MDCT and electroanatomic map for catheter ablation of atrial fibrillation. 
With the use of image integration systems, the anatomy of the left atrium and pulmonary 
veins derived from the MDCT (upper left panel) can be fused with the electroanatomic map 
(upper right panel). The ‘real’ anatomy of the left atrium and pulmonary veins can then be 
used to guide the catheter ablation procedure (lower panel).     
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Table 1 a Diagnostic performance of 64-MDCT for detection of significant coronary stenosis (luminal diameter > 50%):   














Leschka 167 0 67 0/1005 94 (165/176) 95 (805/829) 88 (165/189) 98 (805/816) 
Leber 168 4 55 0/732 76 (57/75) 97 (638/657) 75 (57/76) 97 (638/656) 
Raff 169 0 70 12 (130/1065) 86 (79/92) 95 (802/843) 66 (79/120) 98 (802/815) 
Mollet 170 1 51 0/725 99 (93/94) 95 (601/631) 76 (93/123) 99 (601/602) 
Ropers 171 3 81 4 (45/1128) 93 (39/42) 97 (1010/1041) 56 (39/70) 100 (1010/1013) 
Schuijf 172 1 60 1.4 (12/854) 85 (62/73) 98 (755/769) 82 (62/76) 99 (755/766) 
Ong 35 2 134 9.7 (143/1474) 82 (177/217) 96 (1067/1114) 83 (177/214) 96 (1067/1107) 
Ehara 173 2 69 8 (72/956) 90 (275/304) 94 (545/580) 89 (275/310) 95 (545/574) 
Nikolaou 174 4 72 10 (10/1015) 82 (97/118) 95 (762/805) 72 (97/140) 97 (762/783) 
Total (weighted) 17 659 5.6 (503/8954) 88 (1044/1181) 96 (6985/7269) 79 (1044/1318) 98 (6985/7122) 
Excl. Pat. (N): Number of excluded Patients, NP: Number of patients, PPV: Positive Predictive Value, NPV: Negative Predictive Value
 68
 
Table 1 b  Diagnostic performance of 64-MDCT for detection of significant coronary stenosis (luminal diameter > 50%):   
 Patient-based analysis 
 








Leschka 167 67 100 (47/47) 100 (20/20) 100 (47/47) 100 (20/20) 
Leber 168 45 88 (22/25) 85 (17/20) 88 (22/25) 85 (17/20) 
Raff 169 70 95 (38/40)  90 (27/30) 93 (38/41) 93 (27/29) 
Mollet 170 51 100 (38/38) 92 (12/13) 97 (38/39)          100 (12/12) 
Ropers 171 81 96 (25/26) 91 (50/55) 83 (25/30) 98 (50/51) 
Schuijf 172 60 94 (29/31) 97 (28/29) 97(29/30) 93 (27/29) 
Ehara 173 67 98 (59/60) 86 (6/7) 98 (59/60) 86 (6/7) 
Nikolaou 174 68 97 (38/39) 79 (23/29) 86 (38/44) 96 (23/24) 
Total (weighted) 509 97(296/203 ) 90 (183/203) 94 (296/316) 95 (183/193) 
NP: Number of patients, PPV: Positive Predictive Value, NPV: Negative Predictive Value 
 
